What can CROs and CMOs expect in 2017?

Top CRO and CMO trends for 2017

From a new administration under president-elect Donald Trump, to continued consolidation, the CRO and CMO industry can expect accelerated change – good or bad – says PCI Synthesis.

Related News

CROS NT acquires PM Clinical Limited

CROS NT acquires clinical division of PM Clinical Limited

Pfizer CentreOne expands contract manufacturing offerings

Pfizer CentreOne: service expansions one step in fulfilling pledge to grow capabilities

(Image: Flamma)

Family-owned Flamma opens $20m cGMP facility in China

Related Products

See more related products